Oculis Holding AG
Sector
Location
Market Cap
USD 903.81 M
Share Price
USD 17.71
Avg Daily Volume
28,805
Change (1 day)
Change (1 year)
Change (YTD)
Glaukos Corporation
USD 94.30
GKOS
PharmaResearch Co., Ltd.
USD 402.32
214450.KQ
Santen Pharmaceutical Co., Ltd.
USD 11.41
4536.T
Bausch Health Companies Inc.
USD 6.77
BHC.TO
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 8.50
300573.SZ
Ocular Therapeutix, Inc.
USD 12.21
OCUL
Tarsus Pharmaceuticals, Inc.
USD 41.50
TARS
Eli Lilly and Company
USD 812.69
LLY
AbbVie Inc.
USD 190.28
ABBV
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
Roche Holding AG
USD 345.06
RO.SW
Novartis AG
USD 116.76
NOVN.SW
AstraZeneca PLC
USD 145.14
AZN.L
Abbott Laboratories
USD 126.54
ABT
Merck & Co., Inc.
USD 84.71
MRK
Date | Depreciation And Amortization | Dividends Paid | Common Stock Issued | Common Stock Repurchased |
---|
Glaukos Corporation
USD 94.30
GKOS
PharmaResearch Co., Ltd.
USD 402.32
214450.KQ
Santen Pharmaceutical Co., Ltd.
USD 11.41
4536.T
Bausch Health Companies Inc.
USD 6.77
BHC.TO
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 8.50
300573.SZ
Ocular Therapeutix, Inc.
USD 12.21
OCUL
Tarsus Pharmaceuticals, Inc.
USD 41.50
TARS
Eli Lilly and Company
USD 812.69
LLY
AbbVie Inc.
USD 190.28
ABBV
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
Roche Holding AG
USD 345.06
RO.SW
Novartis AG
USD 116.76
NOVN.SW
AstraZeneca PLC
USD 145.14
AZN.L
Abbott Laboratories
USD 126.54
ABT
Merck & Co., Inc.
USD 84.71
MRK